Metraipolis › archive › dc_7927abe93ebe

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports — Europe PMC PMID:41892505

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41892505
DOI
10.3390/clinpract16030061
License (as archived)
solo-consultazione
Archived
2026-11-04T19:06:45.383Z
SHA-256 of the archived text
b8a258ed7833aff2f8fd46bf7f2fff046c86d20df16b5cc6d6cf7457403c207b
Stable URL of this page
https://metraipolis.com/documento/dc_7927abe93ebe

How to cite

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports — Europe PMC PMID:41892505 — Europe PMC (en), https://europepmc.org/article/MED/41892505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7927abe93ebe (Metraipolis archive dc_7927abe93ebe, sha256 b8a258ed7833aff2f8fd46bf7f2fff046c86d20df16b5cc6d6cf7457403c207b)
BibTeX
@misc{dc7927abe93ebe,
  title = {Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports — Europe PMC PMID:41892505},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41892505},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7927abe93ebe; sha256 b8a258ed7833aff2f8fd46bf7f2fff046c86d20df16b5cc6d6cf7457403c207b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892505. Agents can read the archived copy with the MCP tool read_document.